Initial experience with a newer generation coronary stent

Journal of Invasive Cardiology

Volumn 13, Issue 3, 2001, Pages 217-222

  Manolis, Antonis S ^a,b   Chiladakis, John ^a   Hahalis, George ^a   Agelopoulos, George ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b Department of Cardiology ^*  (Greece)

Author keywords

Coronary angioplasty; Coronary artery disease; Coronary stents; Restenosis

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTICLE; FEMALE; HEART INFARCTION; HUMAN; IMPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDY; PROSTHESIS; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; ANGINA PECTORIS; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; PROSTHESIS IMPLANTATION; STENTS;

EID: 0035290952     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Fischman DL, Leon MB, Baim DS, et al., for the Stent Restenosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
2. Serruys PW, Emanuelsson H, Van der Giessen W, et al., on behalf of the Benestent-II Study Group. Heparin-coated Palmaz-Schatz stents in human coronary arteries: Early outcome of the Benestent-II Pilot study. Circulation 1996;93:412-422.
3. Pentousis D, Guerin Y, Funck F, et al. Direct stent implantation without predilation using the Multi-Link stent. Am J Cardiol 1998;82:1437-1440.
4. Bertrand OF, Sipehia R, Mongrain R, et al. Biocompatibility aspects of new stent technology. J Am Coll Cardiol 1998;32:562-571.
5. Edelman ER, Rogers C. Stent-versus-stent equivalency trials: Are some stents more equal than others? Circulation 1999;100:896-898.
6. Ellis SG, Vandormael MG, Cowley MJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: Implications for patient selection. Circulation 1990;82:1193-1202.
7. Holmes DR Jr., Hirshfeld J Jr., Faxon D, et al. ACC expert consensus document on coronary artery stents. J Am Coll Cardiol 1998;32:1471-1482.
8. Steinhubl SR, Lauer MS, Mukherjee DP, et al. The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non-Q wave myocardial infarctions. J Am Coll Cardiol 1998;32:1366-1370.
9. Mishkel GJ, Aguire FV, Ligon RW, et al. Clopidogrel as adjunctive antiplatelet therapy during coronary stenting. J Am Coll Cardiol 1999;34:1884-1890.
10. Kereiakes DJ, Lincoff AM, Miller DP, et al., for the EPILOG Investigators. Abciximab therapy and unplanned coronary stent deployment. Circulation 1998;97:857-864.
11. Metz D, Meyer P, Touati C, et al. Comparison of 6F with 7F and 8F guiding catheters for elective coronary angioplasty: Results of a prospective, multicenter, randomized trial. Am Heart J 1997;134:131-137.
12. Kornowski R, Bhargava B, Fuchs S, et al. Procedural results and late clinical outcomes after percutaneous interventions using long (> 25 mm) versus short (< 20 mm) stents. J Am Coll Cardiol 2000;35:612-618.
13. Kobayashi Y, De Gregorio J, Kobayashi N, et al. Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol 1999;34:651-659.
14. Cantor WJ, Lazzam C, Cohen EA, et al. Failed coronary stent deployment. Am Heart J 1998;136:1088-1095.
15. Kutryk MJB, Wardeh AJ, Knook AHM, et al. First clinical experience with the R stent: A new highly flexible stainless steel tube intracoronary stent. Int J Cardiovasc Intervent 1999;2:163-169.
16. Kornowski R, Hong MK, Saucedo J, et al. Procedural results and long-term clinical outcomes following coronary stenting in perimyocardial infarction syndromes. Am J Cardiol 1998;82:1163-1167.
17. Smyth DW, Richards AM, Elliott JM. Direct angioplasty for myocardial infarction: One-year experience in a center with surgical back-up 220 miles away. J Invas Cardiol 1997;9:324-332.
18. Manolis AS. Reduced incidence of clinical restenosis with newer generation stents, stent oversizing and high-pressure deployment: Single-operator experience. Clin Cardiol 2001;24:119-126.
19. Kereiakes DJ, Essell JH, Abbottsmith CW, et al. Abciximab-associated profound thrombocytopenia: Therapy with immunoglobulin and platelet transfusion. Am J Cardiol 1996;78:1161-1163.
20. Deshpande NV, Serruys PW. Asymptomatic restenosis: Should we (re)intervene? An unresolved dilemma. Am Heart J 1998;136:576-577.